Evidence map›Paper›PMID 28476168›Full record

ArticleMolecular neurodegeneration2017

Dioxins and related environmental contaminants increase TDP-43 levels.

Peter E A Ash, Elizabeth A Stanford, Ali Al Abdulatif, Alejandra Ramirez-Cardenas, Heather I Ballance, Samantha Boudeau, Amanda Jeh, James M Murithi, Yorghos Tripodis, George J Murphy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Peter E A AshDepartment of Pharmacology, Boston University School of Medicine, 72 East Concord St., R614, Boston, MA, 02118-2526, USA.
Elizabeth A StanfordDepartment of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.
Ali Al AbdulatifDepartment of Pharmacology, Boston University School of Medicine, 72 East Concord St., R614, Boston, MA, 02118-2526, USA.
Alejandra Ramirez-CardenasDepartment of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.
Heather I BallanceDepartment of Pharmacology, Boston University School of Medicine, 72 East Concord St., R614, Boston, MA, 02118-2526, USA.
Samantha BoudeauDepartment of Pharmacology, Boston University School of Medicine, 72 East Concord St., R614, Boston, MA, 02118-2526, USA.
Amanda JehDepartment of Pharmacology, Boston University School of Medicine, 72 East Concord St., R614, Boston, MA, 02118-2526, USA.
James M MurithiCenter for Regenerative Medicine, Boston University, Boston, MA, 02118, USA.
Yorghos TripodisDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, 02118, USA.
George J MurphyCenter for Regenerative Medicine, Boston University, Boston, MA, 02118, USA.
David H SherrDepartment of Environmental Health, Boston University School of Public Health, Boston, MA, 02118, USA.
Benjamin WolozinDepartment of Pharmacology, Boston University School of Medicine, 72 East Concord St., R614, Boston, MA, 02118-2526, USA. bwolozin@bu.edu.ORCID 0000-0003-2068-1475
Boston University · US

Funding

Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
Stress Granules and the Biology of TDP-43R01ES020395 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2012 to 2016
$4.1M
RNA binding proteins as novel targets in Alzheimer's diseaseR01AG050471 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2015 to 2019
$2.9M
The role of acetylation in regulating pathophysiology of tauR01NS089544 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD, WOLOZIN, BENJAMIN L · 2014 to 2018
$1.9M
NIA NIH HHS P30 AG013846NIA NIH HHS R01 AG050471NIEHS NIH HHS R01 ES020395NINDS NIH HHS R01 NS089544
6 · The paper itself

Abstract

backgroundAmyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative condition that is characterized by progressive loss of motor neurons and the accumulation of aggregated TAR DNA Binding Protein-43 (TDP-43, gene: TARDBP). Increasing evidence indicates that environmental factors contribute to the risk of ALS. Dioxins, related planar polychlorinated biphenyls (PCBs), and polycyclic aromatic hydrocarbons (PAHs) are environmental contaminants that activate the aryl hydrocarbon receptor (AHR), a ligand-activated, PAS family transcription factor. Recently, exposure to these toxicants was identified as a risk factor for ALS.

methodsWe examined levels of TDP-43 reporter activity, transcript and protein. Quantification was done using cell lines, induced pluripotent stem cells (iPSCs) and mouse brain. The target samples were treated with AHR agonists, including 6-Formylindolo[3,2-b]carbazole (FICZ, a potential endogenous ligand, 2,3,7,8-tetrachlorodibenzo(p)dioxin, and benzo(a)pyrene, an abundant carcinogen in cigarette smoke). The action of the agonists was inhibited by concomitant addition of AHR antagonists or by AHR-specific shRNA.

resultsWe now report that AHR agonists induce up to a 3-fold increase in TDP-43 protein in human neuronal cell lines (BE-M17 cells), motor neuron differentiated iPSCs, and in murine brain. Chronic treatment with AHR agonists elicits over 2-fold accumulation of soluble and insoluble TDP-43, primarily because of reduced TDP-43 catabolism. AHR antagonists or AHR knockdown inhibits agonist-induced increases in TDP-43 protein and TARDBP transcription demonstrating that the ligands act through the AHR.

conclusionsThese results provide the first evidence that environmental AHR ligands increase TDP-43, which is the principle pathological protein associated with ALS. These results suggest novel molecular mechanisms through which a variety of prevalent environmental factors might directly contribute to ALS. The widespread distribution of dioxins, PCBs and PAHs is considered to be a risk factor for cancer and autoimmune diseases, but could also be a significant public health concern for ALS.

Indexed as

Amyotrophic Lateral SclerosisAnimalsBrainCell LineDNA-Binding ProteinsEnvironmental PollutantsHumansMaleMiceMice, Inbred C57BLNeuronsPolychlorinated DibenzodioxinsPolycyclic Aromatic HydrocarbonsReceptors, Aryl HydrocarbonDNA-Binding ProteinsEnvironmental PollutantsPolychlorinated DibenzodioxinsPolycyclic Aromatic HydrocarbonsReceptors, Aryl HydrocarbonTARDBP protein, humanTardbp protein, mouseAlpha-synucleinALSAtaxin-2FusGene regulationNeurodegenerationPromoterProtein aggregationToxicantsTranscription

Identifiers

PMID28476168
PMCPMC5420162
OpenAlexW2611885424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.